Feasibility study of S-1 alternate-day and Carboplatin in advanced or recurrent non- small cell lung cancer.
Not Applicable
- Conditions
- advanced or recurrent NSCLC
- Registration Number
- JPRN-UMIN000010593
- Lead Sponsor
- Tokushima university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 33
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with pleural or pericardial effusion ,or ascites. 2) Patients with active double cancer. 3)Patients with significant complications. 4)Patients with serious diarrhea. 5)Patients with active infection. 6)Patients with symptomatic brain metastasis. 7)Being treated with flucytosine, phenytoin,warfarin. 8)Uncontrolled psychiatric disease. 9) allergic more than and equal to grade3. 10)Patients with interstitial pneumonia or pulmonary fibrosis. 11)History of serious allergic reaction with S-1 or CBDCA. 12)Patients with pregnancy or lactation. 13)Patients with HIV,HBV 14)Any patients judged by the investigator to be unfit to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method